Long Ideas - Against a backdrop of growing opioid abuse in the U.S., Endo Health Solutions (NASDAQ:ENDP) announced another step Monday night in its efforts to curb abuse … Continue Reading
Read nowLong Ideas - Intermezzo prescriptions are slowly growing, says Transcept management, but royalty revenue has yet to make a substantial contribution to Transcept Pharmaceuticals’ (NASDAQ:TSPT) top-line. For the third quarter, … Continue Reading
Read now- Monday night, Tekmira Pharmaceuticals (TSE:TKM) (NASDAQ:TKMR) announced that it reached a litigation settlement with Alnylam Pharmaceuticals (NASDAQ:ALNY) and will receive $65 million from Alnylam within ten days, … Continue Reading
Read nowLong Ideas - With Gilead’s (NASDAQ:GILD) reported 100% Hepatitis C virologic response rate over the weekend, rivals Achillion (NASDAQ:ACHN) and Vertex (NASDAQ:VRTX) traded down 15% and 5% respectively … Continue Reading
Read nowQuick Picks - With guidance for Natpara’s Biologic License Application (BLA) by mid-2013, and an earnings beat in the third quarter, shares of NPS Pharmaceuticals (NASDAQ:NPSP) climbed 8% … Continue Reading
Read nowQuick Picks - Oncology-focused Celsion Corp. (NASDAQ:CLSN) announced Friday morning that the Phase III HEAT trial met its unblinding milestone, and top-line data will be released in January … Continue Reading
Read nowLong Ideas - Esbriet (perfenidone) sales in Europe have begun to pick up according to InterMune’s (NASDAQ:ITMN) third quarter results, driven largely (91%) by sales in Germany where … Continue Reading
Read now